Nanobiotix

About:

Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.

Website: http://www.nanobiotix.com

Twitter/X: Nanobiotix

Top Investors: European Investment Bank, Bpifrance, Johnson & Johnson Innovation – JJDC, Seventure Partners, Crédit Mutuel Innovation

Description:

Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.

Total Funding Amount:

$359M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2003-01-01

Founders:

Laurent Levy

Number of Employees:

101-250

Last Funding Date:

2023-12-04

IPO Status:

Public

© 2025 bioDAO.ai